Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/Fak and EGFR Signaling

Cancer Cell - United States
doi 10.1016/j.ccell.2018.11.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rad51 Supports Triple Negative Breast Cancer Metastasis.

Oncotarget
Oncology
2014English

EGFR and HER2 Signaling in Breast Cancer Brain Metastasis

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Suppression of KIF3A Inhibits Triple Negative Breast Cancer Growth and Metastasis by Repressing Rb‐E2F Signaling and EMT

Cancer Science
Cancer ResearchMedicineOncology
2020English

A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways

Cancer Research
Cancer ResearchOncology
2011English

Mutant TP53 Modulates Metastasis of Triple Negative Breast Cancer Through Adenosine A2b Receptor Signaling

Oncotarget
Oncology
2018English

Focal Adhesion Kinase (FAK) Activation by Estrogens Involves GPER in Triple-Negative Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

An EGFR/Src-dependent Β4 Integrin/Fak Complex Contributes to Malignancy of Breast Cancer

Scientific Reports
Multidisciplinary
2015English

AHNAK Suppresses Tumour Proliferation and Invasion by Targeting Multiple Pathways in Triple-Negative Breast Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Naringenin Prevents TGF-β1 Secretion From Breast Cancer and Suppresses Pulmonary Metastasis by Inhibiting PKC Activation

Breast Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy